Order Article Reprints

Rodrigues MT, Michelli APP, Caso GF, de Oliveira PR, Rodrigues-Junior DM, Morale MG, Machado Júnior J, Bortoluci KR, Tamura RE, da Silva TRC, et al. Lysicamine Reduces Protein Kinase B (AKT) Activation and Promotes Necrosis in Anaplastic Thyroid Cancer. Pharmaceuticals. 2023; 16(12):1687. https://doi.org/10.3390/ph16121687

Rodrigues, Mariana Teixeira, Ana Paula Picaro Michelli, Gustavo Felisola Caso, Paloma Ramos de Oliveira, Dorival Mendes Rodrigues-Junior, Mirian Galliote Morale, Joel Machado Júnior, Karina Ramalho Bortoluci, Rodrigo Esaki Tamura, Tamiris Reissa Cipriano da Silva, and et al. 2023. "Lysicamine Reduces Protein Kinase B (AKT) Activation and Promotes Necrosis in Anaplastic Thyroid Cancer" Pharmaceuticals 16, no. 12: 1687. https://doi.org/10.3390/ph16121687

Rodrigues, M. T., Michelli, A. P. P., Caso, G. F., de Oliveira, P. R., Rodrigues-Junior, D. M., Morale, M. G., Machado Júnior, J., Bortoluci, K. R., Tamura, R. E., da Silva, T. R. C., Raminelli, C., Chau, E., Godin, B., Calil-Silveira, J., & Rubio, I. G. S. (2023). Lysicamine Reduces Protein Kinase B (AKT) Activation and Promotes Necrosis in Anaplastic Thyroid Cancer. Pharmaceuticals, 16(12), 1687. https://doi.org/10.3390/ph16121687